Company intelligence / Profile preview

Italian Cassie Pharmaceutical Company

Lainate, Lombardy, Italy

Ownership: Private
Development stage: Other

Overview

Cassiopea is an Italian pharmaceutical company focused on developing and commercializing innovative medical dermatology products. The company specializes in treating skin conditions such as acne, androgenetic alopecia (hair loss), and genital warts through novel topical therapies. Its lead product, Winlevi (clascoterone), is a first-in-class topical androgen receptor inhibitor approved for the treatment of acne. Cassiopea was formerly a subsidiary of Cosmo Pharmaceuticals and was later fully integrated following a public tender offer.

Therapeutic areas: Infectious DiseasesDermatology
Modalities: Small molecule
Industry: Biotech

Partnerships

Sun Pharmaceutical Industries

Beyond the preview

Go deeper on Italian Cassie Pharmaceutical Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Italian Cassie Pharmaceutical Company.

Explore the full profile